Muthu Carl, Maani Jason, Plank Lindsay D, Holden Andrew, Hill Andrew
Auckland Regional Endovascular Unit and Interventional Radiology Services, Auckland City Hospital, Auckland, New Zealand.
J Endovasc Ther. 2007 Oct;14(5):661-8. doi: 10.1177/152660280701400509.
To determine whether the rate of type II endoleaks following endovascular aneurysm repair (EVAR) can be decreased using a branch vessel management strategy.
The branch vessel management strategy consisted of routine intraoperative embolization of all patent inferior mesenteric arteries (IMA) and thrombin injection into all aneurysm sacs that showed branch vessel filling on the "sacogram." Sixty-nine consecutive patients (65 men; median age 77 years, range 58-90) undergoing elective EVAR since the protocol was introduced in July 2003 were included; 69 consecutive patients (65 men; median age 76 years, range 60-90) who underwent EVAR immediately prior to the protocol were used as controls. Primary outcome measures were type II endoleak rates and secondary intervention rates.
The median follow-up was 36 months (range 0.25-72) for the pre-protocol group and 12 months (range 0.25-24) for the post-protocol group. The type II endoleak rate for the pre-protocol group was 26% compared to 14% for the post-protocol group (p=0.14). This difference was not significant on Kaplan-Meir analysis (p=0.23). The 18 type II endoleaks in the pre-protocol group included 14 lumbar endoleaks, 1 IMA endoleak, and 3 combined lumbar and IMA endoleaks. The 10 type II endoleaks in the post-protocol group included 9 lumbar artery endoleaks and 1 IMA endoleak. Ten (14%) patients in the pre-protocol group required 15 interventions for type II endoleak compared to 2 (3%) in the post-protocol group who required 3 secondary procedures for type II endoleak (p=0.03). This difference was not significant on Kaplan-Meier analysis (p=0.22). Of the 12 interventions for lumbar endoleaks, only 5 (42%) were successful.
Although there was a trend toward lower type II endoleak rates with our branch vessel management strategy, this did not reach statistical significance. Our data also indicated that there is a high incidence of lumbar endoleaks, and they are difficult to treat. Therefore, we believe there should be ongoing research into means to prevent lumbar endoleaks.
确定使用分支血管管理策略是否可以降低血管内动脉瘤修复术(EVAR)后II型内漏的发生率。
分支血管管理策略包括术中常规栓塞所有通畅的肠系膜下动脉(IMA),并向所有在“囊造影”中显示有分支血管充盈的动脉瘤腔内注射凝血酶。自2003年7月该方案实施以来,连续纳入69例行择期EVAR的患者(65例男性;中位年龄77岁,范围58 - 90岁);将在该方案实施前立即行EVAR的69例连续患者(65例男性;中位年龄76岁,范围60 - 90岁)作为对照。主要观察指标为II型内漏发生率和二次干预率。
方案实施前组的中位随访时间为36个月(范围0.25 - 72个月),方案实施后组为12个月(范围0.25 - 24个月)。方案实施前组的II型内漏发生率为26%,而方案实施后组为14%(p = 0.14)。在Kaplan - Meier分析中,这种差异无统计学意义(p = 0.23)。方案实施前组的18例II型内漏包括14例腰动脉内漏、1例IMA内漏和3例腰动脉与IMA联合内漏。方案实施后组的10例II型内漏包括9例腰动脉内漏和1例IMA内漏。方案实施前组有10例(14%)患者因II型内漏需要15次干预,而方案实施后组有2例(3%)患者因II型内漏需要3次二次手术(p = 0.03)。在Kaplan - Meier分析中,这种差异无统计学意义(p = 0.22)。在针对腰动脉内漏的12次干预中,仅5次(42%)成功。
尽管我们的分支血管管理策略有降低II型内漏发生率的趋势,但未达到统计学意义。我们的数据还表明腰动脉内漏的发生率很高,且难以治疗。因此,我们认为应该继续研究预防腰动脉内漏的方法。